RCCccRCCprostate cancer
…rs targeting CD70 show early promising results for their use in RCC in preclinical and clinical trials. However, further research a…
115articles mentioning diseases
285disease mentions
1distinct diseases extracted
0%of mentions human-reviewed
Active filtersEntity: prostate cancer ×
prostate cancer
This disease is selected. Its supporting articles are shown below.
Articles mentioning prostate cancer
115 articles · page 4 of 10prostate cancerPCaGBM
…tween gay and bisexual men (GBM) and heterosexual patients with prostate cancer (PCa); however, the role of past military service is unclear. T…
prostate cancerNational Screening Committee
…The debate on prostate cancer screening is life, the universe, and everything boiled down to …
oligometastatic diseaseoligometastatic NSCLCbreast cancernon-small cell lung cancerNSCLC
…esigned studies. To focus on the metastatic setting relevant to oligometastatic disease, trials referring to early-stage (stage I–II) or locally advanc…
prostate cancerUK National Screening Committee
…creening Committee have published their review of screening for prostate cancer.1 As of May 2026, the committee does not recommend population s…
Prostate CancerPCaClinicalTrials.gov
…Purpose The BioCaPPE (Biomarkers of Prostate Cancer/Prevention and Environment) study is a multicentre prospective …
prostate cancerPCaIrreversible electroporation (IRE)radical prostatectomy
…study is the first to map systemic immune dynamics after IRE in prostate cancer using single-cell analysis. 1 week after IRE, peripheral blood …
prostate cancerSCNCTalabostatpembrolizumabBXCL701
…Background Small cell neuroendocrine prostate cancer (SCNC) is a lethal subset of prostate cancer with limited treat…
prostate cancerMicrocytosisMacrocytic anaemiamacrocytosiscolorectal cancerCRCincident cancerCancerliver diseaseNon-Hodgkin’s lymphoma
… (C60–C63) at 38.8% (n=650), which almost entirely consisted of prostate cancer (38.0%; n=637), and malignant neoplasms of digestive organs at …
prostate cancerabirateroneolaparibapalutamidedarolutamideenzalutamideBasic Clin Pharmacol Toxicol
…was conducted between February 2023 and June 2025, including 88 prostate cancer patients who started outpatient treatment. The PC process compr…
prostate cancernivolumabdegarelixNCT04989946pTVG-ARArm 2Arm 3Arm 1
…ation therapy might improve outcome for patients with high-risk prostate cancer. Contrary to our initial hypothesis, this was not improved with…
squamous cell carcinomaprostate cancersolid tumoursStage IV malignant melanomalocally advanced or metastatic solid tumourslocally advanced/metastatic tumours
… pan-cytokeratin; PSGL1, P-selectin glycoprotein ligand-1; SCC, squamous cell carcinoma; SD, stable disease; VISTA, V domain-containing immunoglobulin …